Uwe Platzbecker: He is a role model for how important patient participation and clinical trials are

Quoting Uwe Platzbecker, Head of Medical Department 1, Hematology and Cellular Therapy at Leipzig University, on LinkedIn:

”Yesterday we had our first „Leipzig MDS patient cafe“ about diagnostics and therapeutic approaches for patients with MDS. We had a great discussion with patients and their families. We were also thrilled that one of the first MDS patients in the world treated with Luspatercept also showed up! He has been part of the German PACE trial and is still on Luspatercept for more than 8 years! He is a role model for how important patient participation and clinical trials are!”

For the article click here.
Source: Uwe Platzbecker/LinkedIn